Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma

Citation
T. Yoshikawa et al., Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma, CANCER LETT, 153(1-2), 2000, pp. 7-12
Citations number
27
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
153
Issue
1-2
Year of publication
2000
Pages
7 - 12
Database
ISI
SICI code
0304-3835(20000529)153:1-2<7:PCOVAB>2.0.ZU;2-1
Abstract
We examined plasma levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in 54 patients with gastric carcinoma . Postoperative survival was significantly poorer in patients with plasma V EGF levels more than 10.0 pg/ml at the time of surgery. By an univariate an alysis of the factors affecting survival, serosal invasion, lymph node meta stasis, peritoneal dissemination, lymphatic vessel invasion, curability, an d VEGF proteins were significant. By a multivariate analysis only VEGF leve ls and curability remained significant. Patients with recurrent disease, in cluding liver metastasis, had significantly higher plasma VEGF concentratio ns than those with resectable primary tumors. VEGF, not bFGF, may serve as an independent prognosticator and a sensitive indicator for liver recurrenc e in patients with gastric carcinoma. (C) 2000 Elsevier Science Ireland Ltd . All rights reserved.